$2.94 Billion is the total value of PFM Health Sciences, LP's 71 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 44.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCUS | ARCUS BIOSCIENCES INC | $138,853,000 | +16.1% | 3,431,010 | 0.0% | 4.73% | +34.4% | |
| OM | Sell | OUTSET MED INC | $135,516,000 | -7.6% | 2,940,255 | -0.9% | 4.61% | +7.0% |
| ABBV | ABBVIE INC | $124,094,000 | +25.5% | 916,496 | 0.0% | 4.22% | +45.3% | |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $117,657,000 | -31.2% | 1,091,840 | -30.1% | 4.01% | -20.3% |
| CYTK | Sell | CYTOKINETICS INC | $112,355,000 | -0.5% | 2,465,016 | -22.0% | 3.82% | +15.2% |
| CNC | Buy | CENTENE CORP DEL | $91,668,000 | +49.4% | 1,112,480 | +13.0% | 3.12% | +73.0% |
| AVTR | AVANTOR INC | $87,637,000 | +3.0% | 2,079,657 | 0.0% | 2.98% | +19.3% | |
| LLY | Sell | LILLY ELI & CO | $82,491,000 | -32.1% | 298,643 | -43.2% | 2.81% | -21.3% |
| PFE | New | PFIZER INC | $79,327,000 | – | 1,343,384 | +100.0% | 2.70% | – |
| ERASCA INC | $76,954,000 | -21.6% | 5,191,405 | 0.0% | 2.62% | -9.2% | ||
| IQV | Sell | IQVIA HLDGS INC | $67,160,000 | -21.7% | 238,039 | -33.5% | 2.29% | -9.3% |
| HUM | HUMANA INC | $64,671,000 | +19.2% | 139,420 | 0.0% | 2.20% | +38.1% | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $61,667,000 | – | 523,982 | +100.0% | 2.10% | – |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $61,633,000 | -14.5% | 475,340 | -8.7% | 2.10% | -1.0% |
| CARIBOU BIOSCIENCES INC | $59,418,000 | -32.6% | 4,092,309 | 0.0% | 2.02% | -22.0% | ||
| DHR | DANAHER CORPORATION | $57,804,000 | +8.1% | 175,690 | 0.0% | 1.97% | +25.1% | |
| UNH | Sell | UNITEDHEALTH GROUP INC | $56,016,000 | -1.3% | 111,554 | -23.2% | 1.91% | +14.3% |
| MYGN | Sell | MYRIAD GENETICS INC | $55,909,000 | -39.7% | 2,025,681 | -29.5% | 1.90% | -30.2% |
| JNJ | New | JOHNSON & JOHNSON | $55,593,000 | – | 324,972 | +100.0% | 1.89% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $53,542,000 | -15.1% | 3,805,370 | +15.9% | 1.82% | -1.7% |
| ICUI | ICU MED INC | $52,354,000 | +1.7% | 220,587 | 0.0% | 1.78% | +17.8% | |
| PEN | PENUMBRA INC | $50,881,000 | +7.8% | 177,088 | 0.0% | 1.73% | +24.8% | |
| HCA | Sell | HCA HEALTHCARE INC | $50,259,000 | -47.0% | 195,621 | -49.9% | 1.71% | -38.6% |
| ICLR | ICON PLC | $48,989,000 | +18.2% | 158,183 | 0.0% | 1.67% | +36.8% | |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $48,386,000 | -16.7% | 373,492 | -27.2% | 1.65% | -3.6% |
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $48,118,000 | +0.9% | 45,910,000 | 0.0% | 1.64% | +16.8% | ||
| MRTX | Buy | MIRATI THERAPEUTICS INC | $46,273,000 | -13.0% | 315,449 | +5.0% | 1.58% | +0.8% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $46,046,000 | +29.8% | 2,103,512 | +13.3% | 1.57% | +50.3% |
| AZN | ASTRAZENECA PLCsponsored adr | $45,770,000 | -3.0% | 785,748 | 0.0% | 1.56% | +12.2% | |
| MCK | Sell | MCKESSON CORP | $43,997,000 | -36.8% | 177,000 | -49.3% | 1.50% | -26.8% |
| WAT | WATERS CORP | $43,830,000 | +4.3% | 117,634 | 0.0% | 1.49% | +20.7% | |
| THC | Sell | TENET HEALTHCARE CORP | $42,963,000 | -3.1% | 525,927 | -21.2% | 1.46% | +12.3% |
| CTLT | Buy | CATALENT INC | $41,827,000 | +76.8% | 326,700 | +83.7% | 1.42% | +104.6% |
| New | ISHARES TRcall | $41,635,000 | – | 272,800 | +100.0% | 1.42% | – | |
| SGEN | Sell | SEAGEN INC | $41,514,000 | -32.9% | 268,527 | -26.4% | 1.41% | -22.4% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $41,464,000 | +1.6% | 62,143 | -13.0% | 1.41% | +17.7% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $41,077,000 | – | 464,940 | +100.0% | 1.40% | – |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $40,252,000 | -9.0% | 48,150,000 | 0.0% | 1.37% | +5.4% | ||
| NVRO | Buy | NEVRO CORP | $39,330,000 | -14.0% | 485,135 | +23.5% | 1.34% | -0.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $33,562,000 | -59.5% | 394,058 | -54.4% | 1.14% | -53.1% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $33,173,000 | +16.0% | 3,972,868 | +3.2% | 1.13% | +34.2% |
| CAH | New | CARDINAL HEALTH INC | $32,942,000 | – | 639,783 | +100.0% | 1.12% | – |
| HRTX | Buy | HERON THERAPEUTICS INC | $32,068,000 | +0.2% | 3,512,348 | +17.3% | 1.09% | +16.0% |
| New | SPDR SER TRcall | $27,553,000 | – | 246,100 | +100.0% | 0.94% | – | |
| Sell | SOPHIA GENETICS SAordinary shares | $27,525,000 | -22.4% | 1,952,152 | -3.5% | 0.94% | -10.2% | |
| KRTX | KARUNA THERAPEUTICS INC | $23,199,000 | +7.1% | 177,091 | 0.0% | 0.79% | +24.0% | |
| MOH | MOLINA HEALTHCARE INC | $22,294,000 | +17.2% | 70,088 | 0.0% | 0.76% | +35.8% | |
| NTLA | INTELLIA THERAPEUTICS INC | $21,073,000 | -11.9% | 178,222 | 0.0% | 0.72% | +2.0% | |
| ANTM | New | ANTHEM INC | $19,809,000 | – | 42,734 | +100.0% | 0.67% | – |
| CANO | Sell | CANO HEALTH INC | $17,059,000 | -35.8% | 1,914,639 | -8.6% | 0.58% | -25.6% |
| ISEE | Sell | IVERIC BIO INC | $16,807,000 | -9.1% | 1,005,216 | -11.7% | 0.57% | +5.3% |
| NVAX | Sell | NOVAVAX INC | $12,685,000 | -69.0% | 88,663 | -55.0% | 0.43% | -64.1% |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $12,527,000 | +48.8% | 635,904 | +39.6% | 0.43% | +72.2% |
| BFLY | BUTTERFLY NETWORK INC | $12,231,000 | -35.9% | 1,828,311 | 0.0% | 0.42% | -25.8% | |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $12,004,000 | -47.3% | 3,201,066 | -27.3% | 0.41% | -38.9% |
| INCY | New | INCYTE CORP | $9,500,000 | – | 129,428 | +100.0% | 0.32% | – |
| OSH | New | OAK STR HEALTH INC | $9,258,000 | – | 279,357 | +100.0% | 0.32% | – |
| New | IO BIOTECH INC | $7,744,000 | – | 1,362,144 | +100.0% | 0.26% | – | |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $7,642,000 | -69.3% | 1,088,566 | -50.1% | 0.26% | -64.5% |
| LUNG | Buy | PULMONX CORP | $6,709,000 | +36.5% | 209,193 | +53.2% | 0.23% | +58.3% |
| PMVP | PMV PHARMACEUTICALS INC | $6,661,000 | -22.5% | 288,334 | 0.0% | 0.23% | -10.3% | |
| New | PARDES BIOSCIENCES INC | $5,918,000 | – | 361,528 | +100.0% | 0.20% | – | |
| GILD | Sell | GILEAD SCIENCES INC | $5,590,000 | -88.0% | 76,993 | -88.4% | 0.19% | -86.1% |
| HOWL | WEREWOLF THERAPEUTICS INC | $4,764,000 | -30.6% | 400,000 | 0.0% | 0.16% | -19.8% | |
| KNTE | KINNATE BIOPHARMA INC | $4,683,000 | -23.0% | 264,293 | 0.0% | 0.16% | -11.2% | |
| BLSA | BCLS ACQUISITION CORP | $4,548,000 | -2.0% | 464,103 | 0.0% | 0.16% | +14.0% | |
| JYAC | JIYA ACQUISITION CORP | $4,534,000 | -0.1% | 464,103 | 0.0% | 0.15% | +15.8% | |
| FLDM | FLUIDIGM CORP DEL | $3,844,000 | -40.5% | 980,505 | 0.0% | 0.13% | -31.1% | |
| DXCM | Sell | DEXCOM INC | $2,400,000 | -74.9% | 4,469 | -74.5% | 0.08% | -70.9% |
| PROCEPT BIOROBOTICS CORP | $1,626,000 | -34.4% | 65,000 | 0.0% | 0.06% | -24.7% | ||
| ALNA | ALLENA PHARMACEUTICALS | $168,000 | -34.4% | 284,285 | 0.0% | 0.01% | -25.0% | |
| Exit | ADAPTIMMUNE THERAPEUTICS PLCcall | $0 | – | -291,800 | -100.0% | -0.04% | – | |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -188,243 | -100.0% | -0.06% | – |
| BYSI | Exit | BEYONDSPRING INC | $0 | – | -161,697 | -100.0% | -0.08% | – |
| Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -15,000 | -100.0% | -0.08% | – | |
| VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -544,706 | -100.0% | -0.12% | – |
| CERT | Exit | CERTARA INC | $0 | – | -143,028 | -100.0% | -0.14% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -16,900 | -100.0% | -0.14% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -143,297 | -100.0% | -0.14% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -443,595 | -100.0% | -0.19% | – |
| Exit | NOVAVAX INCnote 3.750% 2/0 | $0 | – | -4,250,000 | -100.0% | -0.22% | – | |
| Exit | HUMANA INCcall | $0 | – | -21,000 | -100.0% | -0.24% | – | |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -1,000,000 | -100.0% | -0.29% | – |
| Exit | DYNAVAX TECHNOLOGIES CORPcall | $0 | – | -521,800 | -100.0% | -0.30% | – | |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -99,375 | -100.0% | -0.31% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -84,455 | -100.0% | -0.31% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -302,532 | -100.0% | -0.31% | – |
| Exit | SIGHT SCIENCES INC | $0 | – | -483,538 | -100.0% | -0.32% | – | |
| Exit | STEVANATO GROUP S P A | $0 | – | -549,002 | -100.0% | -0.41% | – | |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -775,819 | -100.0% | -0.59% | – |
| Exit | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $0 | – | -23,000,000 | -100.0% | -0.62% | – | |
| Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -261,500 | -100.0% | -0.74% | – | |
| Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -612,000 | -100.0% | -1.06% | – | |
| Exit | HORIZON THERAPEUTICS PUB Lcall | $0 | – | -439,400 | -100.0% | -1.42% | – | |
| Exit | SELECT SECTOR SPDR TRcall | $0 | – | -1,602,200 | -100.0% | -1.77% | – | |
| Exit | UNITEDHEALTH GROUP INCcall | $0 | – | -157,200 | -100.0% | -1.81% | – | |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -963,700 | -100.0% | -1.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.